Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Imfinzi (durvalumab, a PD-L1 inhibitor) and Calquence (acalabrutinib, a BTK inhibitor) saw double-digit sales growth too
This precision approach treats weight loss as a personalized science, not a one-size-fits-all protocol
Featured therapies SmartPharmaRX currently compounds GLP-1 medications commonly prescribed for metabolic and weight management care, based on provider direction and clinical requirements
doi:10.1016/j.jacc.2024.08.021 Ouimet M, Hennessy EJ, van Solingen C, et al
US$ 28.85
US$ 21.15
US$ 23.26
US$ 21.03
US$ 20.52
US$ 24.80
US$ 27.35
US$ 22.05
